The results showed that combination of resveratrol and anti-PD-L1 antibody caused significant tumor regression, in comparison with resveratrol only (p < 0.05), with anti-PD-L1 antibody only (p < 0.001), and with saline controls (p < 0.001) (Fig. 7D). This evidence concerns the gene CD274 and neoplasm.